Remodeling of the heart in hypertrophy in animal model swith myosin essential light chain mutations

Katarzyna Kazmierczak, Chen Ching Yuan, Jingsheng Liang, Wenrui Huang, Ana I. Rojasand, Danuta Szczesna-Cordary

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Cardiac hypertrophy represents one of the most important cardiovascular problems yet the mechanisms responsible for hypertrophic remodeling of the heart are poorly understood. In this report we aimed to explore the molecular pathways leading to two different phenotypes of cardiac hypertrophy in transgenic mice carrying mutations in the human ventricular myosin essential light chain (ELC). Mutation-induced alterations in the heart structure and function were studied in two transgenic (Tg) mouse models carrying the A57G (alanine to glycine) substitution or lacking the N-terminal 43 amino acid residues (Δ43) from the ELC sequence. The first model represents an HCM disease as the A57G mutation was shown to cause malignant HCM outcomes in humans. The second mouse model is lacking the region of the ELC that was shown to be important for a direct interaction between the ELC and actin during muscle contraction. Our earlier studies demonstrated that > 7 month old Tg-Δ43 mice developed substantial cardiac hypertrophy with no signs of histopathology or fibrosis. Tg mice did not show abnormal cardiac function compared to Tg-WT expressing the full length human ventricular ELC. Previously reported pathological morphology in Tg-A57G mice included extensive disorganization of myocytes and interstitial fibrosis with no abnormal increase in heart mass observed in > 6 month-old animals. In this report we show that strenuous exercise can trigger hypertrophy and pathologic cardiac remodeling in Tg-A57G mice as early as 3 months of age. In contrast, no exercise-induced changes were noted for Tg-Δ43 hearts and the mice maintained a non-pathological cardiac phenotype. Based on our results, we suggest that exercise-elicited heart remodeling in Tg-A57G mice follows the pathological pathway leading to HCM, while it induces no abnormal response in Tg-Δ43 mice.

Original languageEnglish (US)
Article number353
JournalFrontiers in Physiology
Volume5
DOIs
StatePublished - Sep 22 2014

Fingerprint

Myosin Light Chains
Cardiomegaly
Transgenic Mice
Animal Models
Mutation
Light
Fibrosis
Ventricular Myosins
Phenotype
Muscle Contraction
Alanine
Glycine
Muscle Cells
Actins
Amino Acids

Keywords

  • Cardiac remodeling
  • Histopathology
  • Hypertrophic cardiomyopathy (HCM)
  • Mutation
  • Myosin essential light chain
  • Transgenic mice

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Remodeling of the heart in hypertrophy in animal model swith myosin essential light chain mutations. / Kazmierczak, Katarzyna; Yuan, Chen Ching; Liang, Jingsheng; Huang, Wenrui; Rojasand, Ana I.; Szczesna-Cordary, Danuta.

In: Frontiers in Physiology, Vol. 5, 353, 22.09.2014.

Research output: Contribution to journalArticle

Kazmierczak, Katarzyna ; Yuan, Chen Ching ; Liang, Jingsheng ; Huang, Wenrui ; Rojasand, Ana I. ; Szczesna-Cordary, Danuta. / Remodeling of the heart in hypertrophy in animal model swith myosin essential light chain mutations. In: Frontiers in Physiology. 2014 ; Vol. 5.
@article{1f5219014eaf4144b839ed177ce9b5a8,
title = "Remodeling of the heart in hypertrophy in animal model swith myosin essential light chain mutations",
abstract = "Cardiac hypertrophy represents one of the most important cardiovascular problems yet the mechanisms responsible for hypertrophic remodeling of the heart are poorly understood. In this report we aimed to explore the molecular pathways leading to two different phenotypes of cardiac hypertrophy in transgenic mice carrying mutations in the human ventricular myosin essential light chain (ELC). Mutation-induced alterations in the heart structure and function were studied in two transgenic (Tg) mouse models carrying the A57G (alanine to glycine) substitution or lacking the N-terminal 43 amino acid residues (Δ43) from the ELC sequence. The first model represents an HCM disease as the A57G mutation was shown to cause malignant HCM outcomes in humans. The second mouse model is lacking the region of the ELC that was shown to be important for a direct interaction between the ELC and actin during muscle contraction. Our earlier studies demonstrated that > 7 month old Tg-Δ43 mice developed substantial cardiac hypertrophy with no signs of histopathology or fibrosis. Tg mice did not show abnormal cardiac function compared to Tg-WT expressing the full length human ventricular ELC. Previously reported pathological morphology in Tg-A57G mice included extensive disorganization of myocytes and interstitial fibrosis with no abnormal increase in heart mass observed in > 6 month-old animals. In this report we show that strenuous exercise can trigger hypertrophy and pathologic cardiac remodeling in Tg-A57G mice as early as 3 months of age. In contrast, no exercise-induced changes were noted for Tg-Δ43 hearts and the mice maintained a non-pathological cardiac phenotype. Based on our results, we suggest that exercise-elicited heart remodeling in Tg-A57G mice follows the pathological pathway leading to HCM, while it induces no abnormal response in Tg-Δ43 mice.",
keywords = "Cardiac remodeling, Histopathology, Hypertrophic cardiomyopathy (HCM), Mutation, Myosin essential light chain, Transgenic mice",
author = "Katarzyna Kazmierczak and Yuan, {Chen Ching} and Jingsheng Liang and Wenrui Huang and Rojasand, {Ana I.} and Danuta Szczesna-Cordary",
year = "2014",
month = "9",
day = "22",
doi = "10.3389/fphys.2014.00353",
language = "English (US)",
volume = "5",
journal = "Frontiers in Physiology",
issn = "1664-042X",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Remodeling of the heart in hypertrophy in animal model swith myosin essential light chain mutations

AU - Kazmierczak, Katarzyna

AU - Yuan, Chen Ching

AU - Liang, Jingsheng

AU - Huang, Wenrui

AU - Rojasand, Ana I.

AU - Szczesna-Cordary, Danuta

PY - 2014/9/22

Y1 - 2014/9/22

N2 - Cardiac hypertrophy represents one of the most important cardiovascular problems yet the mechanisms responsible for hypertrophic remodeling of the heart are poorly understood. In this report we aimed to explore the molecular pathways leading to two different phenotypes of cardiac hypertrophy in transgenic mice carrying mutations in the human ventricular myosin essential light chain (ELC). Mutation-induced alterations in the heart structure and function were studied in two transgenic (Tg) mouse models carrying the A57G (alanine to glycine) substitution or lacking the N-terminal 43 amino acid residues (Δ43) from the ELC sequence. The first model represents an HCM disease as the A57G mutation was shown to cause malignant HCM outcomes in humans. The second mouse model is lacking the region of the ELC that was shown to be important for a direct interaction between the ELC and actin during muscle contraction. Our earlier studies demonstrated that > 7 month old Tg-Δ43 mice developed substantial cardiac hypertrophy with no signs of histopathology or fibrosis. Tg mice did not show abnormal cardiac function compared to Tg-WT expressing the full length human ventricular ELC. Previously reported pathological morphology in Tg-A57G mice included extensive disorganization of myocytes and interstitial fibrosis with no abnormal increase in heart mass observed in > 6 month-old animals. In this report we show that strenuous exercise can trigger hypertrophy and pathologic cardiac remodeling in Tg-A57G mice as early as 3 months of age. In contrast, no exercise-induced changes were noted for Tg-Δ43 hearts and the mice maintained a non-pathological cardiac phenotype. Based on our results, we suggest that exercise-elicited heart remodeling in Tg-A57G mice follows the pathological pathway leading to HCM, while it induces no abnormal response in Tg-Δ43 mice.

AB - Cardiac hypertrophy represents one of the most important cardiovascular problems yet the mechanisms responsible for hypertrophic remodeling of the heart are poorly understood. In this report we aimed to explore the molecular pathways leading to two different phenotypes of cardiac hypertrophy in transgenic mice carrying mutations in the human ventricular myosin essential light chain (ELC). Mutation-induced alterations in the heart structure and function were studied in two transgenic (Tg) mouse models carrying the A57G (alanine to glycine) substitution or lacking the N-terminal 43 amino acid residues (Δ43) from the ELC sequence. The first model represents an HCM disease as the A57G mutation was shown to cause malignant HCM outcomes in humans. The second mouse model is lacking the region of the ELC that was shown to be important for a direct interaction between the ELC and actin during muscle contraction. Our earlier studies demonstrated that > 7 month old Tg-Δ43 mice developed substantial cardiac hypertrophy with no signs of histopathology or fibrosis. Tg mice did not show abnormal cardiac function compared to Tg-WT expressing the full length human ventricular ELC. Previously reported pathological morphology in Tg-A57G mice included extensive disorganization of myocytes and interstitial fibrosis with no abnormal increase in heart mass observed in > 6 month-old animals. In this report we show that strenuous exercise can trigger hypertrophy and pathologic cardiac remodeling in Tg-A57G mice as early as 3 months of age. In contrast, no exercise-induced changes were noted for Tg-Δ43 hearts and the mice maintained a non-pathological cardiac phenotype. Based on our results, we suggest that exercise-elicited heart remodeling in Tg-A57G mice follows the pathological pathway leading to HCM, while it induces no abnormal response in Tg-Δ43 mice.

KW - Cardiac remodeling

KW - Histopathology

KW - Hypertrophic cardiomyopathy (HCM)

KW - Mutation

KW - Myosin essential light chain

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=85016973418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016973418&partnerID=8YFLogxK

U2 - 10.3389/fphys.2014.00353

DO - 10.3389/fphys.2014.00353

M3 - Article

AN - SCOPUS:85016973418

VL - 5

JO - Frontiers in Physiology

JF - Frontiers in Physiology

SN - 1664-042X

M1 - 353

ER -